Pablo J Aschner - Epidemiology

Author Information

Pablo J. Aschner is affiliated with the Pontificia Universidad Javeriana in Bogotá, Colombia, where he serves in the Department of Clinical Epidemiology and Biostatistics. He is also associated with the Hospital Universitario San Ignacio, Endocrinology Unit, in Bogotá, Colombia. His extensive academic and clinical expertise positions him as a key figure in the field of endocrinology and epidemiology.

Research Contributions

Pablo J. Aschner has made significant contributions to the field of diabetes research, particularly focusing on Type 2 diabetes, glycemic control, and the intersection of diabetes with other health conditions like COVID-19 and obesity. His work includes the validation of diabetes risk scores, studies on glycemic control metrics, and the exploration of factors associated with physical activity in populations at risk for diabetes. He has participated in international consensus-building efforts and has authored multiple papers addressing the epidemiological aspects of diabetes and its complications.

Aliases

Pablo J. Aschner is also known by several aliases, including P Aschner, P. Aschner, and Pablo Aschner.

Publication and Citation Metrics

Metric	Value
Citation Count	1875
h-index	23
Paper Count	54

Publications:

Validation of the finnish type 2 diabetes risk score (findrisc) with the ogtt in health care practices in europe.

DOI: 10.1016/j.diabres.2021.108976

Year: 2021

Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19

DOI: 10.1016/j.dsx.2021.02.008

Year: 2021

Factors Associated With Low Physical Activity in Two Latin American Populations at Risk of Developing Type 2 Diabetes: An Exploratory Analysis

DOI: 10.3389/fpubh.2020.589484

Year: 2020

The International Diabetes Federation's Guide for Diabetes Epidemiological Studies.

DOI: 10.1016/j.diabres.2020.108630

Year: 2020

COVID-19 in people living with diabetes: An international consensus

DOI: 10.1016/j.jdiacomp.2020.107671

Year: 2020

Obesity and COVID‐19 in Latin America: A tragedy of two pandemics—Official document of the Latin American Federation of Obesity Societies

DOI: 10.1111/obr.13165

Year: 2020

Insulin Therapy in Type 2 Diabetes.

DOI: 10.1097/MJT.0000000000001088

Year: 2019

Changes in the incidence of diabetes mellitus type 1 in children under the age of 15 in the city of Bogotá, Colombia.

DOI: 10.1016/j.endinu.2019.09.002

Year: 2019

Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.

DOI: 10.1016/j.ahj.2019.09.016

Year: 2019

External validation of the Finnish diabetes risk score in Venezuela using a national sample: The EVESCAM.

DOI: 10.1016/j.pcd.2019.04.006

Year: 2019

Why Analyze Health Data?

What is the Role of Clinical Researchers in Epidemiology?

Why is QALY Important in Epidemiology?

What are the Benefits of Being CPH Certified?

What is the Importance of Communication in Epidemiology?

What is DNA Damage?

How is Skin Cancer Detected?

What Is Antimicrobial Resistance and Why Is It a Threat?

How Do Social Determinants of Health Influence Behavior?

How Do Epidemiologists Track Microbes?

Partnered Content Networks

Relevant Topics